squamous-cell carcinoma; SCC
sun exposition (cutaneous SCC)
HPV infection (head and neck SCC, cervical SCC, anal SCC)
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma. (#24909994#)
heand and neck squamous cell carcinoma oral squamous cell carcinoma parotidal squamous cell carcinoma tonsilar squamous cell carcinoma sinusal squamous cell carcinoma hypopharyngeal squamous cell carcinoma laryngeal squamous cell (...)
humpath.com supports the 2015 edition of the European Symposium of Biopathology, June 2015 in Paris, France.
Most recent articles
squamous-cell carcinoma; SCC
Since the latest 2004 publication on lung carcinoma by the World Health Organization Committee and subsequent publications by the International Association for the Study of Lung Cancer, the introduction of terms such as “pulmonary adenocarcinoma in situ” and “minimally invasive adenocarcinoma” to replace the category of what is known as “bronchioloalveolar carcinoma.”
Over the decade 2000-2010, use of the term bronchioloalveolar carcinoma (BAC) has come under constant scrutiny as some (...)
Malignant tumors of the paranasal sinus are uncommon, constituting less than 1% of all malignancies and 3% of all head and neck cancers. Nonsquamous cancers of the maxillary sinus are even rarer as is evident from the limited data available on the clinical characteristics and outcomes. Mucoepidermoid carcinoma accounts for 13% of all malignancies occurring in maxillary sinus.
Mucoepidermoid carcinoma accounts for 13% of all malignancies occurring in maxillary sinus.
Sinusal localisation of Aspergillus sp.
Pulmonary lymphoepithelioma-like carcinoma is morphologically similar to its counterpart in the head and neck area. It is characterized by a prominent syncytial growth pattern and typically has pushing borders to the adjacent pulmonary parenchyma.
Lymphoepithelioma-like carcinoma is an uncommon but distinct form of non-small cell carcinoma that found inclusion into the large cell carcinoma category in the 1999 WHO schema based on the absence of distinct squamous or glandular (...)
Basaloid carcinoma of the lung was first included as a distinct entity in the 1999 WHO schema of lung tumors based on its poorer prognosis when compared to conventional non-small cell lung carcinoma.
In its initial description in 1992, only 50% of the tumors were pure basaloid carcinomas while the rest were associated with areas of squamous cell carcinoma, adenocarcinoma, adenosquamous carcinoma, or classic large cell carcinoma.
The same authors used an arbitrary cutoff of 60% of a (...)
pulmonary large cell neuroendocrine carcinoma
Large cell neuroendocrine carcinoma of the lung, was described in 1991, as a high-grade large cell carcinoma with neuroendocrine morphology and immunohistochemical demonstration of at least one neuroendocrine marker.
From a prognostic point of view, large cell neuroendocrine carcinoma was initially placed between atypical carcinoid and small cell carcinoma but subsequently found to be similar in behavior to small cell carcinoma.
It was (...)
PCA3 is a prostate-specific non-coding RNA, with utility as a urine-based early detection biomarker.
Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization—a correlative study with urine PCA3 and TMPRSS2-ERG. Warrick JI, Tomlins SA, Carskadon SL, Young AM, Siddiqui J, Wei JT, Chinnaiyan AM, Kunju LP, Palanisamy N. Mod Pathol. 2014 Apr;27(4):609-20. doi:10.1038/modpathol.2013.169 . PMID: 24072184 (...)